PPIDT00003
Drug Information
| Name | Dornase alfa |
|---|---|
| Sequence | LKIAAFNIQTFGETKMSNATLVSYIVQILSRYDIALVQEVRDSHLTAVGKLLDNLNQDAPDTYHYVVSEPLGRNSYKERYLFVYRPDQVSAVDSYYYDDGCEPCGNDTFNREPAIVRFFSRFTEVREFAIVPLHAAPGDAVAEIDALYDVYLDVQEKWGLEDVMLMGDFNAGCSYVRPSQWSSIRLWTSPTFQWLIPDSADTTATPTHCAYDRIVVAGMLLRGAVVPDSALPFNFQAAYGLSDQLAQAISDHYPVEVMLK |
| DrugBank_ID | DB00003 |
| Type | biotech |
| Indication | Used as adjunct therapy in the treatment of cystic fibrosis. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Aerosol, spray | Respiratory (inhalation) |
2.5 mg
|
| Solution | Respiratory (inhalation) |
1 mg / mL
|
| Solution | Respiratory (inhalation) |
1 mg/1mL
|
| Solution | Respiratory (inhalation) |
2.5 mg/2.5ml
|
| Solution | Respiratory (inhalation) |
|
| Solution | Respiratory (inhalation) |
2500 E./2.5ml
|
| Solution | Respiratory (inhalation) |
250000 mg
|